FDA Approved: RIVASTIGMINE TRANSDERMAL SYSTEM — Original Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved Breckenridge Pharmaceutical's rivastigmine transdermal system (patch) through an Original ANDA, expanding generic options for treating mild to mode…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine transdermal system (Rivastigmine)

Snippet

ORIG AP for RIVASTIGMINE TRANSDERMAL SYSTEM (RIVASTIGMINE)